Table 3

Effects of temperature, osmolarity, endocytosis inhibitors, and metabolic inhibitor on the acid-resistant binding of125I-labeled C-AVP4-9 to MBEC4

ConditionAcid-Resistant Binding
% of control
Control100  ± 7.4
Low temperature (4°C)10.4  ± 1.23-c
Hypertonic (1600 mOsM)53.4  ± 14.93-b
Dancylcadaverine (0.5 mM)74.3  ± 3.73-b
2,4-Dinitrophenol (1 mM)26.0  ± 3.93-c
Control3-a 100  ± 14.6
Phenylarsine oxide (0.1 mM)3-a 44.4  ± 8.03-b
  • After preincubation for 30 min, 125I-labeled C-AVP4-9 and [3H]inulin were incubated under the indicated conditions at 4° or 37°C for 60 min. Each value represents the percentage of acid-resistant binding of125I-labeled C-AVP4-9 (as cell/medium ratios) versus the control value (mean ± S.E. of three or four separate experiments).

  • 3-a Because phenylarsine oxide was dissolved in 0.1% dimethyl sulfoxide, the control experiment was performed in the presence of 0.1% dimethyl sulfoxide.

  • 3-b Significant inhibition (p < .05).

  • 3-c Significant inhibition (p < .001).